FI53700C - FRAMEWORK FOR THE ADMINISTRATION OF THERAPEUTIC THERAPEUTIC DIAMINOPROPIOFENONDERIVAT - Google Patents

FRAMEWORK FOR THE ADMINISTRATION OF THERAPEUTIC THERAPEUTIC DIAMINOPROPIOFENONDERIVAT

Info

Publication number
FI53700C
FI53700C FI3330/70A FI333070A FI53700C FI 53700 C FI53700 C FI 53700C FI 3330/70 A FI3330/70 A FI 3330/70A FI 333070 A FI333070 A FI 333070A FI 53700 C FI53700 C FI 53700C
Authority
FI
Finland
Prior art keywords
therapeutic
diaminopropiofenonderivat
framework
administration
therapeutic therapeutic
Prior art date
Application number
FI3330/70A
Other languages
Finnish (fi)
Other versions
FI53700B (en
Inventor
Kurt Thiele
Walter Von Bebenburg
Klaus Posselt
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of FI53700B publication Critical patent/FI53700B/fi
Application granted granted Critical
Publication of FI53700C publication Critical patent/FI53700C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrrole Compounds (AREA)
FI3330/70A 1969-12-18 1970-12-10 FRAMEWORK FOR THE ADMINISTRATION OF THERAPEUTIC THERAPEUTIC DIAMINOPROPIOFENONDERIVAT FI53700C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1178769A AT305987B (en) 1969-12-18 1969-12-18 Process for the preparation of new aminoketones

Publications (2)

Publication Number Publication Date
FI53700B FI53700B (en) 1978-03-31
FI53700C true FI53700C (en) 1978-07-10

Family

ID=3630679

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3330/70A FI53700C (en) 1969-12-18 1970-12-10 FRAMEWORK FOR THE ADMINISTRATION OF THERAPEUTIC THERAPEUTIC DIAMINOPROPIOFENONDERIVAT

Country Status (16)

Country Link
JP (1) JPS5245701B1 (en)
AT (1) AT305987B (en)
BE (1) BE760505A (en)
CA (1) CA992979A (en)
CH (4) CH566288A5 (en)
DE (1) DE2061864C3 (en)
DK (1) DK137380B (en)
ES (3) ES385918A1 (en)
FI (1) FI53700C (en)
FR (1) FR2081381B1 (en)
GB (1) GB1332930A (en)
NL (1) NL164552C (en)
SE (1) SE383874B (en)
SU (3) SU470108A3 (en)
YU (1) YU35434B (en)
ZA (1) ZA708151B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279925A (en) 1980-01-25 1981-07-21 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
US4276307A (en) 1980-01-25 1981-06-30 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
US4279929A (en) 1980-01-25 1981-07-21 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
US4285970A (en) 1980-01-25 1981-08-25 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
US4305960A (en) 1980-01-25 1981-12-15 Shell Oil Company N-Phenethylaminopropiophenones as lipogenesis inhibitors
IL156669A0 (en) 2003-06-26 2004-01-04 Neurim Pharma 1991 2-aminobenzoyl derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6609318A (en) * 1966-07-04 1968-01-05

Also Published As

Publication number Publication date
CH566289A5 (en) 1975-09-15
ES395207A1 (en) 1975-03-16
CH566963A5 (en) 1975-09-30
CA992979A (en) 1976-07-13
AT305987B (en) 1973-03-26
YU35434B (en) 1981-02-28
SU493956A3 (en) 1975-11-28
NL164552B (en) 1980-08-15
DE2061864B2 (en) 1979-06-28
NL164552C (en) 1981-01-15
FI53700B (en) 1978-03-31
YU292770A (en) 1980-06-30
SE383874B (en) 1976-04-05
FR2081381B1 (en) 1974-03-22
NL7017884A (en) 1971-06-22
CH566288A5 (en) 1975-09-15
GB1332930A (en) 1973-10-10
SU440826A3 (en) 1974-08-25
ES385918A1 (en) 1973-05-01
DE2061864C3 (en) 1980-03-13
FR2081381A1 (en) 1971-12-03
ZA708151B (en) 1971-12-29
DK137380C (en) 1978-07-31
DK137380B (en) 1978-02-27
CH566290A5 (en) 1975-09-15
JPS5245701B1 (en) 1977-11-17
BE760505A (en) 1971-05-27
DE2061864A1 (en) 1971-10-14
SU507224A3 (en) 1976-03-15
ES395209A1 (en) 1975-03-01
SU470108A3 (en) 1975-05-05

Similar Documents

Publication Publication Date Title
FI54301C (en) FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC THERAPEUTIC KINAZOLINDERIVAT
NO138807C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE E 3-MARKAPTOTIADIAZOLE OR MARKAPTOTETRAZOLE-CEPHALOSPORINE
FI54916C (en) FRAMEWORK FOR THERAPEUTIC TREATMENT OF NUTRITIONAL N-SUBSTITUTE 2-PYRROLIDONER
SE414497B (en) PROCEDURE FOR PREPARATION OF P-CARBONYLOXIM-PHENOXIAL COOL-CARBOXAMIDES
FI48062C (en) Process for the preparation of xylitol
FI53897B (en) FRAMEWORK FOR THE FRAMEWORK OF THE FRAMEWORK
FI55184C (en) PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC VERKSAMY PHENYL-2-PYRROLIDINONER SAMT DERAS ISOMERER
FI54099B (en) ANALOGIFICATION OF FRAMEWORK FOR THERAPEUTIC ACTIVATION
SE402451B (en) PROCEDURE FOR THE PREPARATION OF 14-DESOXI-14-ACETOXIMUTILINE
SE7511680L (en) PROCEDURE FOR THE PREPARATION OF FURANDE DERIVATIVES
FI54100B (en) FRAMEWORK FOR THERAPEUTIC TREATMENT OF THERAPEUTIC TRICYCLES
FI54602B (en) FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC THERAPY OF 6-AMIDINOPENICILLANSYRADERIVAT
FI54104C (en) FRAMEWORK FOR THERAPEUTIC TREATMENT
FI53700C (en) FRAMEWORK FOR THE ADMINISTRATION OF THERAPEUTIC THERAPEUTIC DIAMINOPROPIOFENONDERIVAT
SE384685B (en) PROCEDURE FOR THE PREPARATION OF LINKOMYCIN DERIVATIVES
FI53967C (en) FRAMEWORK FOR THERAPEUTIC ADJUSTMENT OF THERAPEUTIC BENSOBICYCLOALKANAMINER
BR6915239D0 (en) THERAPEUTIC AGENTS
SE394668B (en) PROCEDURE FOR THE PREPARATION OF 2-ETHYLHEXANE-1-AL
FI55338C (en) PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC VERIFICATION N-METHYL IMIDAZOLER
NO137050C (en) PROCEDURES FOR THE PREPARATION OF BUTYROFENONE DERIVATIVES
BE759692A (en) MINERAL-VEGETABLE MEDICINE
FI56171B (en) FRAMEWORK FOR THE PREPARATION OF THERAPEUTIC ACTIVATED ACYLES
BR6915086D0 (en) THERAPEUTIC AGENTS
BE760692A (en) THERAPEUTIC COMPOSITIONS
SE404606B (en) PROCEDURE FOR THE PREPARATION OF 3-METHYLHALOGEN-CEPHALOSPORINE COMPOUNDS